Group 1 - The core event is the "National Hospital Investor Reception Day" scheduled for October 30, where investors can interact with the company's CEO, hospital directors, and leading experts [2][3] - The theme of this year's event is "Intelligent Leadership in New Journey," focusing on showcasing the operational status of hospitals and the company's advancements in AI, new technologies, and services [2][3][4] - The event aims to deepen investors' understanding of the industry and the company, having been held annually since 2019, effectively creating a long-term channel for engagement [3][4] Group 2 - The company emphasizes that despite challenges such as consumer confidence and healthcare cost control, the fundamental characteristics of the ophthalmology sector remain strong, with a focus on digital ophthalmology and AI empowerment [3] - The event has a "zero-threshold" registration policy, allowing all investors, regardless of shareholding, to participate, fostering an inclusive environment for feedback and suggestions [4] - The company has a strong track record in investor relations, having received multiple awards for best practices and maintaining a consistent cash dividend policy, with a total dividend payout of 7.12 billion since its IPO [4]
“智领新程” 爱尔眼科将举办第七届“全国医院投资者接待日”活动